Nanoinformatics: An emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology

Biological Research

Volumn 44, Issue 1, 2011, Pages 43-51

  González Nilo, Fernando ^a   Pérez Acle, Tomás ^b   Guínez Molinos, Sergio ^a   Geraldo, Daniela A ^a   Sandoval, Claudia ^a   Yévenes, Alejandro ^a   Santos, Leonardo S ^a   Laurie, V Felipe ^a   Mendoza, Hegaly ^a   Cachau, Raúl E ^c  

^a UNIVERSIDAD DE TALCA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c SAIC FREDERICK INC   (United States)

Author keywords

Bioinformatics; Molecular simulation; Nanobiotechnology; Nanoinformatics; Nanomedicine

Indexed keywords

ARTICLE; BIOLOGY; BIOMEDICINE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; MEDICAL INFORMATICS; METHODOLOGY; NANOTECHNOLOGY;

BIOLOGICAL SCIENCE DISCIPLINES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; MEDICAL INFORMATICS; MICROCHEMISTRY; MODELS, MOLECULAR; NANOTECHNOLOGY;

EID: 79957937396     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602011000100006     Document Type: Article

References (98)

1. ACTION-GRID PROJECT. PORTAL, URL: (HTTP://www.ACTION-GRID.EU/).vol. Last Access, March 2010.
2. ARAYNE MS, SULTANA N, QURESHI F (2007) Review: nanoparticles in delivery of cardiovascular drugs. Pak J Pharm Sci 20:340-348.
3. ARCHAKOV AI, IVANOV YD (2007) Analytical nanobiotechnology for medicine diagnostics. Mol Biosyst 3:336-342.
4. ARTIGAS RA., GONZÁLEZ A, RIQUELME E, CARVAJAL CA, CATTANI A, Martínez-Aguayo A, KALERGIS AM, Pérez-Acle T, FARDELLA CE (2008a) A novel Acth receptor (Mc2r) mutation alters its structure and function, causing familial glucocorticoid deficiency. J Clin Endocrinol Metab.
5. ARTIGAS RA, GONZÁLEZ A, RIQUELME E, CARVAJAL CA, CATTANI A, Martínez-Aguayo A, KALERGIS AM, Perez-Acle T, FARDELLA CE (2008b) A novel adrenocorticotropin receptor mutation alters its structure and function, causing familial glucocorticoid deficiency. J Clin Endocrinol Metab 93, 3097-3105.
6. BARRÍA MI, GONZÁLEZ A, Vera-Otárola J, LEÓN U, VOLLRATH V, MARSAC D, MONASTERIO O, Pérez-Acle T, SOZA A, LÓPEZLASTRA M (2009) Analysis of natural variants of the hepatitis C virusinternal ribosome entry site reveals that primary sequence plays a key role in cap-independent translation. Nucleic Acids Res 37:957-971.
7. BELTING M, WITTRUP A (2009) Macromolecular drug delivery: Basic principles and therapeutic applications. Molec Biotechnol 43:89-94.
8. BEWICK S, YANG R, ZHANG M (2009) Complex mathematical models of biology at the nanoscale. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1.
9. BIANCO A (2004) Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv 1:57-65.
10. CARVAJAL CA, GONZÁLEZ AA, ROMERO DG, GONZÁLEZ A, MOSSO LM, LAGOS ET, HEVIA MDEL P, ROSATI MP, Pérez-Acle TO, Gómez-Sánchez CE, MONTERO JA, FARDELLA CE (2003) Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess. J Clin Endocrinol Metab 88:2501-2507.
11. CASE DA, CHEATHAM TE 3RD, DARDEN T, GOHLKE H, LUO R, MERZ KM JR., ONUFRIEV A, SIMMERLING C, WANG B, WOODS RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668-1688.
12. CIEPLAK M, THOMPSON D (2008) Coarse-grained molecular dynamics simulations of nanopatterning with multivalent inks. J Chem Phys 128:234906.
13. COLOMBRES M, GARATE JA, LAGOS CF, Araya-Secchi R, NORAMBUENA P, QUIROZ S, LARRONDO L, Pérez-Acle T, EYZAGUIRRE J (2008) An eleven amino acid residue deletion expands the substrate specificity of acetyl xylan esterase II (AXE II) from Penicillium purpurogenum. J Comput Aided Mol Des 22:19-28.
14. CHOTHIA C, LESK AM (1986) The relation between the divergence of sequence and structure in proteins. EMBO J 5:823-826.
15. CHOTHIA C, LESK AM, LEVITT M, AMIT AG, MARIUZZA RA, PHILLIPS SE, POLJAK RJ (1986) The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science 233:755-758.
16. DAGGETT V (2001) Molecular dynamics simulations of protein unfolding/folding. Methods Mol Biol 168:215-247.
17. DATABASE OF NANOPARTICLES, http://nanobiology.utalca.cl.vol. Last Access, December 2009.
18. DE LA CALLE G, Garcia-Remesal M, CHIESA S, DE LA IGLESIA D, MAOJO V (2009) BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature. BMC Bioinformatics 10:320.
19. de la CALLE G, García-Remesal M, MAOJO V (2008) A method for indexing biomedical resources over the Internet. Studies in Health Technology and Informatics 136:163.
20. DIEKMANN S, LINDHORST T (2002) Dendrimers. Reviews in Molecular Biotechnology 90, 157-158.
21. DREXLER KE (1992) Nanotechnology: The past and the future. Science 255, 268-269.
22. EHRENFELD N, GONZÁLEZ A, CANON P, MEDINA C, Pérez-Acle T, Arce-Johnson P (2008) Structure-function relationship between the tobamovirus TMV-Cg coat protein and the HR-like response. J Gen Virol 89:809-817.
23. ERICKSON B (2009) Nanomaterial data remain scarce. Chemical & Engineering 87:42. ETP NANOMEDICINE, HTTP://www.ETP-NANOMEDICINE.EU/PUBLIC/PRESS-DOCUMENTS/PUBLICATIONS/091022_ETPN_REPORT_2009.
24. PDF (October 22, 2009). Roadmaps in Nanomedicine, vol. Last Access, December 2009.
25. EYZAGUIRRE J, SIGALA C, Pérez-Acle T, CORTES P, PEIRANO A (2004) Importance of the "thumb" for the catalytic activity of endoxylanase B (Xyn B) from Penicillium purpurogenum. Faseb J 18:C146-C147.
26. FAN D, HAO J (2009) Magnetic aligned vesicles. Journal of Colloid andInterface Science.
27. FAROKHZAD O, LANGER R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Advanced Drug Delivery Reviews 58:1456-1459.
28. FERMEGLIA M PRICL S (2009) Multiscale molecular modeling in nanostructured material design and process system engineering. Computers and Chemical Engineering 33:1701-1710.
29. FREDDOLINO PL, ARKHIPOV AS, LARSON SB, MCPHERSON A, SCHULTEN K (2006). Molecular dynamics simulations of the complete satellite tobacco mosaic virus. Structure 14:437-449.
30. FREITAS R (2005) What is nanomedicine? Disease-a-Month 51:325-341.
31. FUNDING AND SUPPORT FOR INTERNATIONAL NANOTECHNOLOGY COLLABORATIONS NANOFORUM REPORT, http://www.nanoforum.org. (December 2005). vol. Last Access, December 2009.
32. GAO H (2001) Modelling strategies for nano-and biomaterials. European White Book on Fundamental Research in Materials Science. Stuttgart (Germany): Max Planck Gesellschaft, GMBH 144-148.
33. García-Remesal M, MAOJO V, CRESPO J, BILLHARDT H (2007) Logical schema acquisition from text-based sources for structured and nonstructured biomedical sources integration, vol. 2007, pp. 259. American Medical Informatics Association.
34. GATES T, HINKLEY J (2004) Computational materials: Modeling and simulation of nanostructured materials and systems, vol. 2, pp. 1872-1876. Citeseer.
35. GATES T, ODEGARD G, FRANKLAND S, CLANCY T (2005) Computational materials: multi-scale modeling and simulation of nanostructured materials. Composites Science and Technology 65, 2416-2434.
36. GOGONEA V, SUÁREZ D, VAN DER VAART A, MERZ KM JR (2001) New developments in applying quantum mechanics to proteins. Curr Opin Struct Biol 11:217-223.
37. González-Ibanez A, González-Nilo F, CACHAU R (2009) The Collaboratory for Structural Nanobiology. Biophys J 96:49.
38. González-Nilo D, CACHAU R (2008) Nanoinformatics versus bioinformatics. 5 RIB (Red Iberoamericana de Bioinformática) Congress Pontificie U. Catolica de Chile, Chile
39. GONZÁLEZ A, DURAN LS, Araya-Secchi R, GARATE JA, PESSOAMAHANA CD, LAGOS, C. F. & Pérez-Acle T (2008) Computational modeling study of functional microdomains in cannabinoid receptor type 1. Bioorg Med Chem 16:4378-4389.
40. GORDON N, SAGMAN U (2003) Nanomedicine Taxonomy of the Canadian Institute for Health Research (CIHR).
41. Haddish-Berhane N, RICKUS J, HAGHIGHI K (2007) The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems. Internat J Nanomed 2:315. http://www.charmm.org/html/documentation/c34b1/energy.html,U.,vol. Last Access, March 2010.
42. IGLESIA DDL, CHIESA S, KERN J, MAOJO V, Matin-Sánchez F, POTAMIAS G (2009) Nanoinformatics: New challenges for biomedical informatics at the nano level. Medical Informatics in a United and Healthy Europe.
43. INESTROSA NC, ÁLVAREZ A, DINAMARCA MC, Pérez-Acle T, COLOMBRES M (2005) Acetylcholinesterase-amyloid-beta-peptide interaction: effect of Congo Red and the role of the Wnt pathway. Curr Alzheimer Res 2:301-306.
44. INSTITUTE OF NANOTECHNOLOGY FORUM, URL: http://www.nano.org.uk/forum/index.php.vol. Last Access, March 2010.
45. KANG W, CHAE J, CHO Y, LEE J, KIM S (2009) Multiplex imaging of single tumor cells using quantum-dot-conjugated aptamers. Small (Weinheim an der Bergstrasse, Germany).
46. KHURANA E, NIELSEN SO, ENSING B, KLEIN ML (2006) Self-assembling cyclic peptides: molecular dynamics studies of dimers in polar and nonpolar solvents. J Phys Chem B 110:18965-18972.
47. LAGOS CF, CABALLERO J, González-Nilo FD, DAVID PESSOAMAHANA C, Pérez-Acle T (2008) Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Chem Biol Drug Des 72:360-369.
48. LEE H, YANG H, HOLLOWAY P (2009a) Functionalized CdS nanospheres and nanorods. Physica B: Physics of Condensed Matter.
49. LEE S, FERRARI M, DECUZZI P (2009b) Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20:495101.
50. LEE W, PIAO L, PARK C, LIM Y, DO Y, YOON S, KIM S (2009c) Facile synthesis and size control of spherical aggregates composed of Cu2O nanoparticles. Journal of Colloid and Interface Science.
51. LIZAMA C, LAGOS CF, Lagos-Cabre R, CANTUARIAS L, RIVERA F, HUENCHUNIR P, PEREZ-ACLE T, CARRION F, MORENO RD (2009) Calpain inhibitors prevent p38 MAPK activation and germ cell apoptosis after heat stress in pubertal rat testes. J Cell Physiol 221:296-305.
52. LU D, AKSIMENTIEV A, SHIH AY, Cruz-Chu E, FREDDOLINO PL, ARKHIPOV A, SCHULTEN K. (2006) The role of molecular modeling in bionanotechnology. Phys Biol 3:S40-53.
53. LUNDSTROM K (2007) Structural genomics and drug discovery. J Cell Mol Med 11:224-238.
54. FRISCH MJ, G. W. T., SCHLEGEL HB, SCUSERIA GE, ROBB MA, CHEESEMAN JR, MONTGOMERY JA JR, VREVEN T, KUDIN KN, BURANT JC, MILLAM JM, IYENGAR SS, TOMASI J, BARONE V, MENNUCCI B, COSSI M, SCALMANI G, REGA N, PETERSSON GA, NAKATSUJI H, HADA M, EHARA M, TOYOTA K, FUKUDA R, HASEGAWA J, ISHIDA M, NAKAJIMA T, HONDA Y, KITAO O, NAKAI H, KLENE M, LI X, KNOX JE, HRATCHIAN HP, CROSS JB, BAKKEN V, ADAMO C, JARAMILLO J, GOMPERTS R, STRATMANN RE, YAZYEV O, AUSTIN AJ, CAMMI R, POMELLI C, OCHTERSKI JW, AYALA PY, MOROKUMA K, VOTH GA, SALVADOR P, DANNENBERG JJ, ZAKRZEWSKI VG, DAPPRICH S, DANIELS AD, STRAIN MC, FARKAS O, MALICK DK, RABUCK AD, RAGHAVACHARI K, FORESMAN JB, ORTIZ JV, CUI Q, BABOUL AG, CLIFFORD S, CIOSLOWSKI J, STEFANOV BB, LIU G, LIASHENKO A, PISKORZ P, KOMAROMI I, MARTIN RL, FOX DJ, KEITH T, AL-LAHAM MA, PENG CY, NANAYAKKARA A, CHALLACOMBE M, GILL PMW, JOHNSON B, CHEN W, WONG MW, GONZALEZ C, POPLE JA (2004) Gaussian (ed. Gaussian I), Wallingford CT:
55. MACKERELL AD JR, BANAVALI N, FOLOPPE N (2000) Development and current status of the CHARMM force field for nucleic acids. Biopolymers 56:257-265.
56. MARTIN W, ZHU W, KRILOV G (2008) Simulation study of noncovalent hybridization of carbon nanotubes by single-stranded DNA in water. J Phys Chem B 112:16076-16089.
57. MAUGER B, HUNTER J, DRENNAN J, WRIGHT A, OHAGAN T (2007) Building a data grid for the Australian Nanostructural Analysis Network, pp. 312-319. IEEE Computer Society: Washington, DC, USA.
58. MCGUFFIN LJ, JONES DT (2002) Targeting novel folds for structural genomics. Proteins 48:44-52.
59. MILANESI L, ROMANO P, CASTELLANI G, REMONDINI D, LIÚ P (2009) Trends in modeling biomedical complex systems. BMC Bioinformatics 10:I1.
60. MURALI MOHAN Y, VIMALA K, THOMAS V, VARAPRASAD K, SREEDHAR B, BAJPAI S, MOHANA RAJU K (2009) Controlling of silver nanoparticles structure by hydrogel networks. Journal of Colloid and Interface Science.
61. NANOHUB FORUM NNFCN http://www.nanohub.org.vol. Last Access, December 2009.
62. NANOLINK is a portal web, http://www.nano-link.net Nano life quality through innovation by a network of knowledge, vol. Last Access, December 2009.
63. NANOMEDNET http://www.nano.org.uk/nanomednet/vol. Last Access, March 2010.
64. NANONEWSBOARD FORUM http://www.amtexpo.com/nano/vol. Last Access, March 2010.
65. NANOWERK NANOTECHNOLOGY PORTAL http://www.nanowerk.comvol. Last Access, December 2009.
66. NATIONAL INSTITUTES OF HEALTH (NIH), NIOHRFMRN http://hidroadmap.nih.gov/nanomedicine (2006) vol. Last Access, December 2009.
67. NEWKOME G, SHREINER C (2007) Poly (amidoamine), polypropylenimine, and related dendrimers and dendrons possessing different 1 2 branching motifs: An overview of the divergent procedures. Polymer.
68. PATRA M, KARTTUNEN M (2004) Systematic comparison of force fields for microscopic simulations of NaCl in aqueous solutions: diffusion, free energy of hydration, and structural properties. J Comput Chem 25:678-89.
69. PONDER JW, CASE DA (2003) Force fields for protein simulations. Adv Protein Chem 66:27-85.
70. PRASAD K, JHA A (2010) Biosynthesis of CdS nanoparticles: An improved green and rapid procedure. Journal of Colloid and Interface Science 342:68-72.
71. PRICE DJ BROOKS CL 3RD (2002) Modern protein force fields behave comparably in molecular dynamics simulations. J Comput Chem 23:1045-1057.
72. PROYECTO NBIC http://biotic.isciii.es/Biotic/NBIC.html.vol. Last Access, March 2010.
73. RICKMAN J, LESAR R (2003) Computational Materials Research.
74. RODRIGUEZ A (2008) NBIC-NANO, BIO, INFO, COGNO LA CONVERGENCIA DE TECNOLOGIAS. La Habana, Cuba.
75. SALI A BLUNDELL TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
76. SALI A, LIMA CD, KOSTIC M (2007) Structural genomics. Structure 15:1341.
77. SALI A, POTTERTON L, YUAN F, VAN VLIJMEN H, KARPLUS M (1995) Evaluation of comparative protein modeling by MODELLER. Proteins 23:318-326.
78. SANCHEZ R, SALI A (2000) Comparative protein structure modeling. Introduction and practical examples with modeller. Methods Mol Biol 143:97-129.
79. SELIM W, LEE C (2009) Bioinspired application of dendrimers: From biomimicry to biomedical applications. Prog Polymer Sci 34:
80. SHAPIRO B, BINDEWALD E, KASPRZAK W, YINGLING Y (2008) Protocols for the in silico design of RNA nanostructures. Methods Molec Biol 474:93.
81. SIBEKO B, PILLAY V, CHOONARA Y, KHAN R, MODI G, IYUKE S, NAIDOO D, DANCKWERTS M (2009) Computational molecular modeling and structural rationalization. Biomedical Materials 4:015014.
82. SOMMERFELD D, LINGNER T, STANKE M, MORGENSTERN B, RICHTER H (2009) AUGUSTUS AT MEDIGRID: Adaption of a bioinformatics application to grid computing for efficient genome analysis. Future Generation Computer Systems 25:337-345.
83. STAGGERS N, MCCASKY T, BRAZELTON N, KENNEDY R (2008) Nanotechnology: The coming revolution and its implications for consumers, clinicians, and informatics. Nursing Outlook 56:268-274.
84. STANGE C, MATUS JT, DOMÍNGUEZ C, Pérez-Acle T, Arce-Johnson P (2008) The N-homologue LRR domain adopts a folding which explains the TMV-Cg-induced HR-like response in sensitive tobacco plants. J Mol Graph Model 26:850-860.
85. STROBEL P, ALLARD C, ASPILLAGA A, Perez-Acle T, LEIGHTON F (2004) Role of glucose transporters (GLUT) on flavonoid transport. Free Radical Biology and Medicine 36:S151-S151.
86. STROBEL P, ALLARD C, Pérez-Acle T, CALDERÓN R, ALDUNATE R, LEIGHTON F (2005) Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 386:471-478.
87. TALBI E, ZOMAYA A (2007) Grid Computing for Bioinformatics and Computational Biology. Wiley-Interscience.
88. TENTONI L (2003) A model-based approach to the assessment of physicochemical properties of drug delivery materials. Computers & Chemical Engineering 27;.
89. THE CANCER BIOMEDICAL INFORMATICS GRID (CABIG) https://cabig.nci.nih.gov/overview/.vol. Last Access, March 2010.
90. THE CANCER NANOTECHNOLOGY LABORATORY (CANANOLAB) PORTAL: http://cananolab.abcc.ncifcrf.gov/caNanoLab/welcome.do.vol. Last Access, March 2010.
91. THE COLLABORATORY FOR STRUCTURAL NANOBIOLOGY (CSN) http://csn.ncifcrf.gov/csn.vol. Last Access, March 2010.
92. THE ICON EHS DATABASE http://icon.rice.edu/research.cfm.vol. Last Access, March 2010.
93. THIERRY B (2009) Drug nanocarriers and functional nanoparticles: Applications in cancer therapy. Curr Drug Deliv 6:391-403.
94. TISCHLER ND, GONZALEZ A, Perez-Acle T, ROSEMBLATT M, VALENZUELA PD (2005) Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J Gen Virol 86:2937-2947.
95. TOMALIA DA (2005) The dendritic state. Materials Today 8:34-46.
96. VASQUEZ D, LAGOS CF, Mella-Raipan J, GONZALEZ L, EBENSPERGER R, Alvarez-Figueroa MJ, SAEZ E, PESSOAMAHANA H, Araya-Secchi R, Gonzalez-Wong A, PEREZACLE T, Pessoa-Mahana CD (2007) 1-benzoyl-2-(2-nitrophenyl)-1Hbenzimidazole derivatives: A novel approach to the development of new HIV-1 reverse transcriptase inhibitors. Journal of the Chilean Chemical Society 52:1281-1287.
97. ZIMMERLI U, KOUMOUTSAKOS P (2008) Simulations of electrophoretic RNA transport through transmembrane carbon nanotubes. Biophys J 94:2546-2557.
98. ZWEIGENBAUM P, Demner-Fushman D, YU H, COHEN K (2007) Frontiers of biomedical text mining: current progress. Briefings Bioinformatics 8:358.